awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37295966-C207A8DF-5CD5-469F-B6F7-2A8F64E503D3
Q37295966-C207A8DF-5CD5-469F-B6F7-2A8F64E503D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37295966-C207A8DF-5CD5-469F-B6F7-2A8F64E503D3
An evolution in switching therapy for psoriasis patients who fail to meet treatment goals.
P2860
Q37295966-C207A8DF-5CD5-469F-B6F7-2A8F64E503D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37295966-C207A8DF-5CD5-469F-B6F7-2A8F64E503D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b46e216d0aafdf42f6976a1931ce555d97df331f
P2860
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)